Medical Device News Magazine

New York Bone & Joint Specialists: New Invention Stops or Delays the Progression of Osteoarthritis of the Knee

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

April 1, 2021

New York Bone & Joint Specialists is at the forefront of orthopedic technology, with an exciting invention focused on preventing the development and/or progression of osteoarthritis of the knee.

At the same time, this invention can be used to promote and accelerate the healing of any orthopedically repaired tissue.

Leon E. Popovitz, MD, co-founder of New York Bone & Joint Specialists and top orthopedic surgeon in NYC, has invented a bone and joint implant device that has the potential to counteract the effects of osteoarthritis. As a result, the device would diminish the need for joint replacement surgery, and save billions of dollars in medical costs.

The invention is an anchor that increases blood circulation to soft tissue. It features a unique network of channels that are designed to maximize blood flow and rejuvenate vital structures, such as the meniscus, in a degenerating knee. Thus, a patient who suffers from the beginnings of osteoarthritis of the knee may completely avoid the long and painful process of managing their deteriorating joint and eventually receiving a knee replacement. Instead, their knee may become rejuvenated without the need for joint replacement surgery.

Dr. Popovitz and his team have completed bench testing and cadaver intraoperative testing for this patented implant. Further studies are still in process.

“Millions of people suffer from knee osteoarthritis and millions undergo extensive joint replacement therapy,” says Dr. Popovitz. “My implant serves to replenish circulation to the meniscus, which functions by protecting the knee joint from degeneration. The invention, therefore, works by preserving the knee joint itself.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”